Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
6(75.0%)
Phase 4
2(25.0%)
8Total
N/A(6)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07563582Not ApplicableRecruiting

Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia

Role: collaborator

NCT07393360Not ApplicableRecruiting

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Role: lead

NCT07308769Phase 4Recruiting

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

Role: lead

NCT07299851Not ApplicableRecruiting

Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing

Role: lead

NCT07287371Phase 4Not Yet Recruiting

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

Role: collaborator

NCT06137833Not ApplicableRecruiting

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

Role: lead

NCT06137820Not ApplicableUnknown

CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle

Role: lead

NCT06134115Not ApplicableCompleted

LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4

Role: lead

All 8 trials loaded